speb/financial-data huggingface dataset:
CRON.TO balance_sheet (quarterly, 2025-03-31) — Inventory: 34603000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Invested Capital: 1066403000.00
CRON.TO cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -55356000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 2755000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 6347000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Loans Receivable: 737000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 840000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 840000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 37820000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Minority Interest: 48362000.00
CRON.TO income_statement (quarterly, 2025-03-31) — Minority Interests: -1601000.00
CRON.TO cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
CRON.TO cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: -1583000.00
CRON.TO income_statement (quarterly, 2025-03-31) — Net Income: 6122000.00
CRON.TO income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 6122000.00
CRON.TO income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 7723000.00
CRON.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 6122000.00
CRON.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 6122000.00
CRON.TO cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 7723000.00
CRON.TO income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 7723000.00
CRON.TO cash_flow (quarterly, 2025-03-31) — Net Intangibles Purchase And Sale: -98000.00
CRON.TO income_statement (quarterly, 2025-03-31) — Net Interest Income: 9665000.00
CRON.TO cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: -40000000.00
CRON.TO income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 9665000.00
CRON.TO cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -2930000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Net PPE: 140505000.00
CRON.TO cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -15258000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 992510000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 2506000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 4563000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 2506000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 4563000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Non Current Note Receivables: 15587000.00
CRON.TO income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -1754000.00
CRON.TO income_statement (quarterly, 2025-03-31) — Normalized Income: 5206550.00
CRON.TO cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -2096000.00
CRON.TO cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -1515000.00
CRON.TO income_statement (quarterly, 2025-03-31) — Operating Income: -3517000.00
CRON.TO income_statement (quarterly, 2025-03-31) — Operating Revenue: 41898000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 385406395.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 6313000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 13000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -66449000.00
CRON.TO income_statement (quarterly, 2025-03-31) — Other Gand A: 9309000.00
CRON.TO income_statement (quarterly, 2025-03-31) — Other Income Expense: 1120000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 10625000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Other Investments: 2755000.00
CRON.TO cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 1296000.00
CRON.TO income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 43000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Other Properties: 1320000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Other Receivables: 7354000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 40000000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Payables: 9511000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 32058000.00
CRON.TO income_statement (quarterly, 2025-03-31) — Pretax Income: 7268000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
CRON.TO income_statement (quarterly, 2025-03-31) — Provision For Doubtful Accounts: 0.00
CRON.TO cash_flow (quarterly, 2025-03-31) — Provisionand Write Offof Assets: 9000.00
CRON.TO cash_flow (quarterly, 2025-03-31) — Purchase Of Intangibles: -98000.00
CRON.TO cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -40000000.00
CRON.TO cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -15258000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Raw Materials: 5343000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Receivables: 31757000.00
CRON.TO income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 16184000.00
CRON.TO income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 2840000.00
CRON.TO cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: 0.00
CRON.TO income_statement (quarterly, 2025-03-31) — Research And Development: 793000.00
CRON.TO income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: 555000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 463816000.00
CRON.TO income_statement (quarterly, 2025-03-31) — Salaries And Wages: 2088000.00
CRON.TO cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 0.00
CRON.TO income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 4565000.00
CRON.TO income_statement (quarterly, 2025-03-31) — Selling General And Administration: 15962000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Share Issued: 385406395.00
CRON.TO income_statement (quarterly, 2025-03-31) — Special Income Charges: -555000.00
CRON.TO cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 2088000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 1066403000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 992510000.00
CRON.TO income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 161550.00
CRON.TO income_statement (quarterly, 2025-03-31) — Tax Provision: -455000.00
CRON.TO income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.15
CRON.TO balance_sheet (quarterly, 2025-03-31) — Total Assets: 1153827000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 1066403000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Total Debt: 1817000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 1114765000.00
CRON.TO income_statement (quarterly, 2025-03-31) — Total Expenses: 35779000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 39062000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 235246000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 6014000.00
CRON.TO income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -4072000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 12000.00
CRON.TO income_statement (quarterly, 2025-03-31) — Total Unusual Items: 1077000.00
CRON.TO income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 1077000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Tradeand Other Payables Non Current: 0.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Work In Process: 15809000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Working Capital: 885533000.00
CRON.TO income_statement (quarterly, 2025-03-31) — Write Off: 0.00
CRON.TO income_statement (quarterly, 2025-06-30) — +Operating Expense: 19060000.00
CRON.TO income_statement (quarterly, 2025-06-30) — +Total Revenue: 33455000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 12136000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 26619000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Accrued Interest Receivable: 3228000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -144753000.00
CRON.TO cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: 0.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Assets Held For Sale Current: 6022000.00
CRON.TO income_statement (quarterly, 2025-06-30) — Basic Average Shares: 385306213.00
CRON.TO income_statement (quarterly, 2025-06-30) — Basic EPS: -0.10
CRON.TO cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 797819000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Buildings And Improvements: 239415000.00
CRON.TO cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -3838000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 2011000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Capital Stock: 666614000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 794416000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 834416000.00
CRON.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -7686000.00
CRON.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -983000.00
CRON.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 2818000.00
CRON.TO cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 581000.00
CRON.TO cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 865000.00
CRON.TO cash_flow (quarterly, 2025-06-30) — Change In Income Tax Payable: 0.00
CRON.TO cash_flow (quarterly, 2025-06-30) — Change In Inventory: -5086000.00
CRON.TO cash_flow (quarterly, 2025-06-30) — Change In Payable: 581000.00
CRON.TO cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 1446000.00
CRON.TO cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 1446000.00
CRON.TO cash_flow (quarterly, 2025-06-30) — Change In Receivables: -5290000.00
CRON.TO cash_flow (quarterly, 2025-06-30) — Change In Tax Payable: 0.00
CRON.TO cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -7484000.00
CRON.TO cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -6385000.00
CRON.TO cash_flow (quarterly, 2025-06-30) — Changes In Cash: -5851000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Common Stock: 666614000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 1082290000.00
CRON.TO cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -3612000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Construction In Progress: 634000.00
CRON.TO income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 18951000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 24637000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Current Assets: 927147000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 822000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 822000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 37612000.00
CRON.TO cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 4202000.00
CRON.TO income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 867000.00
CRON.TO cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 4202000.00
CRON.TO income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 867000.00
CRON.TO income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 385306213.00
CRON.TO income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.10
CRON.TO income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -39711000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Dueto Related Parties Non Current: 680000.00
CRON.TO income_statement (quarterly, 2025-06-30) — EBIT: -4556000.00
CRON.TO income_statement (quarterly, 2025-06-30) — EBITDA: -354000.00
CRON.TO income_statement (quarterly, 2025-06-30) — Earnings From Equity Interest: 0.00
CRON.TO cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 2448000.00
CRON.TO cash_flow (quarterly, 2025-06-30) — End Cash Position: 794416000.00
CRON.TO income_statement (quarterly, 2025-06-30) — Excise Taxes: 10797000.00
CRON.TO cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -7686000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Finished Goods: 12432000.00
CRON.TO cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -1020000.00
CRON.TO cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: 632000.00
CRON.TO income_statement (quarterly, 2025-06-30) — Gain On Sale Of Ppe: -2501000.00
CRON.TO income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: -40178000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -8404000.00
CRON.TO income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 11917000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Goodwill: 66918000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 77483000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Gross PPE: 296673000.00
CRON.TO income_statement (quarterly, 2025-06-30) — Gross Profit: 14504000.00
CRON.TO income_statement (quarterly, 2025-06-30) — Impairment Of Capital Assets: 0.00
CRON.TO cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 9000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Income Tax Payable: 14000.00
CRON.TO income_statement (quarterly, 2025-06-30) — Interest Income: 8997000.00
CRON.TO income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 8997000.00
CRON.TO cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 0.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Inventory: 42142000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Invested Capital: 1082290000.00
CRON.TO cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -983000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 2251000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Land And Improvements: 6875000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Loans Receivable: 0.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 1189000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 1189000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 48072000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Minority Interest: 47916000.00
CRON.TO income_statement (quarterly, 2025-06-30) — Minority Interests: -1229000.00
CRON.TO cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -3612000.00
CRON.TO cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: 39538000.00
CRON.TO income_statement (quarterly, 2025-06-30) — Net Income: -39711000.00
CRON.TO income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -39711000.00
CRON.TO income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -38482000.00
CRON.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -39711000.00
CRON.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -39711000.00
CRON.TO cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -38482000.00
CRON.TO income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -38482000.00
CRON.TO cash_flow (quarterly, 2025-06-30) — Net Intangibles Purchase And Sale: -1000.00
CRON.TO income_statement (quarterly, 2025-06-30) — Net Interest Income: 8997000.00
CRON.TO cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 0.00
CRON.TO income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 8997000.00
CRON.TO cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -4074000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Net PPE: 151920000.00
CRON.TO cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -3837000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 1004807000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 2659000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 5540000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 2659000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 5540000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Non Current Note Receivables: 13767000.00
CRON.TO income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 43093000.00
CRON.TO income_statement (quarterly, 2025-06-30) — Normalized Income: 3151241.50
CRON.TO cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 2818000.00
CRON.TO cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 42671000.00
CRON.TO income_statement (quarterly, 2025-06-30) — Operating Income: -4556000.00
CRON.TO income_statement (quarterly, 2025-06-30) — Operating Revenue: 44252000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 383806912.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 5191000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 3000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -8404000.00
CRON.TO income_statement (quarterly, 2025-06-30) — Other Gand A: 10536000.00
CRON.TO income_statement (quarterly, 2025-06-30) — Other Income Expense: -43448000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 10565000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Other Investments: 2251000.00
CRON.TO cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 550000.00
CRON.TO income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: -1000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Other Properties: 1677000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Other Receivables: 9529000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 40000000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Payables: 12150000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 36787000.00
CRON.TO income_statement (quarterly, 2025-06-30) — Pretax Income: -39007000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
CRON.TO cash_flow (quarterly, 2025-06-30) — Provisionand Write Offof Assets: -20000.00
CRON.TO cash_flow (quarterly, 2025-06-30) — Purchase Of Intangibles: -1000.00
CRON.TO cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: 0.00
CRON.TO cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -3837000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Raw Materials: 6003000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Receivables: 39376000.00
CRON.TO income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 15616000.00
CRON.TO income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 4202000.00
CRON.TO cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -3612000.00
CRON.TO income_statement (quarterly, 2025-06-30) — Research And Development: 929000.00
CRON.TO income_statement (quarterly, 2025-06-30) — Restructuring And Mergern Acquisition: 768000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 424080000.00
CRON.TO income_statement (quarterly, 2025-06-30) — Salaries And Wages: 1381000.00
CRON.TO cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 0.00
CRON.TO income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 5347000.00
CRON.TO income_statement (quarterly, 2025-06-30) — Selling General And Administration: 17264000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Share Issued: 383806912.00
CRON.TO income_statement (quarterly, 2025-06-30) — Special Income Charges: -3269000.00
CRON.TO cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 1381000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 1082290000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 1004807000.00
CRON.TO income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -584758.50
CRON.TO income_statement (quarterly, 2025-06-30) — Tax Provision: -525000.00
CRON.TO income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.01
CRON.TO balance_sheet (quarterly, 2025-06-30) — Total Assets: 1175227000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 1082290000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Total Debt: 2011000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 1130206000.00
CRON.TO income_statement (quarterly, 2025-06-30) — Total Expenses: 38011000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 45021000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 248080000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 7409000.00
CRON.TO income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -5324000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 14000.00
CRON.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items: -43447000.00
CRON.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -43447000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Tradeand Other Payables Non Current: 0.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Work In Process: 23707000.00
CRON.TO balance_sheet (quarterly, 2025-06-30) — Working Capital: 889535000.00
CRON.TO income_statement (quarterly, 2025-06-30) — Write Off: 0.00
CRON.TO income_statement (quarterly, 2025-09-30) — +Operating Expense: 23358000.00
CRON.TO income_statement (quarterly, 2025-09-30) — +Total Revenue: 36339000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 10865000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 27091000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Accrued Interest Receivable: 6548000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -145239000.00
CRON.TO cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 36000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Assets Held For Sale Current: 2873000.00
CRON.TO cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 794416000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Buildings And Improvements: 234824000.00
CRON.TO cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -4588000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 1742000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Capital Stock: 666147000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 784170000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 824170000.00
CRON.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -1866000.00
CRON.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -23002000.00
CRON.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 13309000.00
CRON.TO cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -171000.00
CRON.TO cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 4283000.00
CRON.TO cash_flow (quarterly, 2025-09-30) — Change In Income Tax Payable: -13000.00
CRON.TO cash_flow (quarterly, 2025-09-30) — Change In Inventory: -6308000.00
CRON.TO cash_flow (quarterly, 2025-09-30) — Change In Payable: -184000.00
CRON.TO cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 4099000.00
CRON.TO cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -3734000.00
CRON.TO cash_flow (quarterly, 2025-09-30) — Change In Receivables: 151000.00
CRON.TO cash_flow (quarterly, 2025-09-30) — Change In Tax Payable: -13000.00
CRON.TO cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -5792000.00
CRON.TO cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -716000.00
CRON.TO cash_flow (quarterly, 2025-09-30) — Changes In Cash: -11559000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Common Stock: 666147000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 1082504000.00
CRON.TO cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -1859000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 469000.00
CRON.TO income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 18007000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 29625000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Current Assets: 922151000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 576000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 576000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 41067000.00
CRON.TO cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 3532000.00
CRON.TO income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 354000.00
CRON.TO cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 3532000.00
CRON.TO income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 354000.00
CRON.TO income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 25958000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Dueto Related Parties Non Current: 698000.00
CRON.TO income_statement (quarterly, 2025-09-30) — EBIT: -5026000.00
CRON.TO income_statement (quarterly, 2025-09-30) — EBITDA: -1494000.00
CRON.TO income_statement (quarterly, 2025-09-30) — Earnings From Equity Interest: 0.00
CRON.TO cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 1313000.00
CRON.TO cash_flow (quarterly, 2025-09-30) — End Cash Position: 784170000.00
CRON.TO income_statement (quarterly, 2025-09-30) — Excise Taxes: 12489000.00
CRON.TO cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -1866000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Finished Goods: 13224000.00
CRON.TO cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 8721000.00
CRON.TO cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: -4182000.00
CRON.TO income_statement (quarterly, 2025-09-30) — Gain On Sale Of Ppe: -3031000.00
CRON.TO income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 23851000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -33675000.00
CRON.TO income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 11587000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Goodwill: 65413000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 75242000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Gross PPE: 292304000.00
CRON.TO income_statement (quarterly, 2025-09-30) — Gross Profit: 18332000.00
CRON.TO income_statement (quarterly, 2025-09-30) — Impairment Of Capital Assets: 36000.00
CRON.TO cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 9000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Income Tax Payable: 1000.00
CRON.TO income_statement (quarterly, 2025-09-30) — Interest Income: 11742000.00
CRON.TO income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 11742000.00
CRON.TO cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 0.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Inventory: 48167000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Invested Capital: 1082504000.00
CRON.TO cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -23002000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 11443000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Land And Improvements: 7091000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Loans Receivable: 176000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 1166000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 1166000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 48391000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Minority Interest: 49545000.00
CRON.TO income_statement (quarterly, 2025-09-30) — Minority Interests: -2363000.00
CRON.TO cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -1859000.00
CRON.TO cash_flow (quarterly, 2025-09-30) — Net Foreign Currency Exchange Gain Loss: -19785000.00
CRON.TO income_statement (quarterly, 2025-09-30) — Net Income: 25958000.00
CRON.TO income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 25958000.00
CRON.TO income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 28321000.00
CRON.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 25958000.00
CRON.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 25958000.00
CRON.TO cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 28321000.00
CRON.TO income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 28321000.00
CRON.TO cash_flow (quarterly, 2025-09-30) — Net Intangibles Purchase And Sale: -105000.00
CRON.TO income_statement (quarterly, 2025-09-30) — Net Interest Income: 11742000.00
CRON.TO cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -5107000.00
CRON.TO income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 11742000.00
CRON.TO cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -7000.00
CRON.TO cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: -13307000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Net PPE: 147065000.00
CRON.TO cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -4483000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 1007262000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 100000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 3430000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 100000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 3430000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Non Current Note Receivables: 22409000.00
CRON.TO income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -22066000.00
CRON.TO income_statement (quarterly, 2025-09-30) — Normalized Income: 8471800.00
CRON.TO cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 13309000.00
CRON.TO cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -20936000.00
CRON.TO income_statement (quarterly, 2025-09-30) — Operating Income: -5026000.00
CRON.TO income_statement (quarterly, 2025-09-30) — Operating Revenue: 48828000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 382893267.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 8769000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -33675000.00
CRON.TO income_statement (quarterly, 2025-09-30) — Other Gand A: 9254000.00
CRON.TO income_statement (quarterly, 2025-09-30) — Other Income Expense: 20289000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 9829000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Other Investments: 11443000.00
CRON.TO cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 1038000.00
CRON.TO income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -283000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Other Properties: 1529000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Other Receivables: 4357000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 40000000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Payables: 10866000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 40491000.00
CRON.TO income_statement (quarterly, 2025-09-30) — Pretax Income: 27005000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
CRON.TO income_statement (quarterly, 2025-09-30) — Provision For Doubtful Accounts: 4771000.00
CRON.TO cash_flow (quarterly, 2025-09-30) — Provisionand Write Offof Assets: 4777000.00
CRON.TO cash_flow (quarterly, 2025-09-30) — Purchase Of Intangibles: -105000.00
CRON.TO cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -5107000.00
CRON.TO cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -4483000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Raw Materials: 6540000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Receivables: 38172000.00
CRON.TO income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 14829000.00
CRON.TO income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 3532000.00
CRON.TO cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -1859000.00
CRON.TO income_statement (quarterly, 2025-09-30) — Research And Development: 1345000.00
CRON.TO income_statement (quarterly, 2025-09-30) — Restructuring And Mergern Acquisition: 212000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 450032000.00
CRON.TO income_statement (quarterly, 2025-09-30) — Salaries And Wages: 2333000.00
CRON.TO cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 0.00
CRON.TO income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 5301000.00
CRON.TO income_statement (quarterly, 2025-09-30) — Selling General And Administration: 16888000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Share Issued: 382893267.00
CRON.TO income_statement (quarterly, 2025-09-30) — Special Income Charges: -3279000.00
CRON.TO cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 2333000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 1082504000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 1007262000.00
CRON.TO income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 3085800.00
CRON.TO income_statement (quarterly, 2025-09-30) — Tax Provision: -1316000.00
CRON.TO income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.15
CRON.TO balance_sheet (quarterly, 2025-09-30) — Total Assets: 1178410000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 1082504000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Total Debt: 1742000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 1132049000.00
CRON.TO income_statement (quarterly, 2025-09-30) — Total Expenses: 41365000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 46361000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 256259000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 5294000.00
CRON.TO income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -503000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 1000.00
CRON.TO income_statement (quarterly, 2025-09-30) — Total Unusual Items: 20572000.00
CRON.TO income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 20572000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Tradeand Other Payables Non Current: 0.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Work In Process: 28403000.00
CRON.TO balance_sheet (quarterly, 2025-09-30) — Working Capital: 881084000.00
CRON.TO income_statement (quarterly, 2025-09-30) — Write Off: 0.00
CRON.TO income_statement (annual, 2025-12-31) — +Operating Expense: 82256000.00
CRON.TO income_statement (quarterly, 2025-12-31) — +Operating Expense: 22587000.00
CRON.TO income_statement (annual, 2025-12-31) — +Total Revenue: 146587000.00
CRON.TO income_statement (quarterly, 2025-12-31) — +Total Revenue: 44531000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Accounts Payable: 11640000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 11640000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Accounts Receivable: 34099000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 34099000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Accrued Interest Receivable: 8654000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Accrued Interest Receivable: 8654000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -149461000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -149461000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -9000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -9000.00
CRON.TO cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 736000.00
CRON.TO cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 700000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Assets Held For Sale Current: 0.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Assets Held For Sale Current: 0.00
CRON.TO income_statement (annual, 2025-12-31) — Basic Average Shares: 383468522.00
CRON.TO income_statement (quarterly, 2025-12-31) — Basic Average Shares: 382531225.00
CRON.TO income_statement (annual, 2025-12-31) — Basic EPS: -0.02
CRON.TO income_statement (quarterly, 2025-12-31) — Basic EPS: 0.00
CRON.TO cash_flow (annual, 2025-12-31) — Beginning Cash Position: 858805000.00
CRON.TO cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 784170000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 236811000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 236811000.00
CRON.TO cash_flow (annual, 2025-12-31) — Capital Expenditure: -26056000.00
CRON.TO cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -2274000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 1509000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 1509000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Capital Stock: 662983000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Capital Stock: 662983000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 791794000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 791794000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 831794000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 831794000.00
CRON.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -19905000.00
CRON.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -7423000.00
CRON.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -76559000.00
CRON.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 2782000.00
CRON.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 25866000.00
CRON.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 11835000.00
CRON.TO cash_flow (annual, 2025-12-31) — Change In Account Payable: 1108000.00
CRON.TO cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 2335000.00
CRON.TO cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 2438000.00
CRON.TO cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 6168000.00
CRON.TO cash_flow (annual, 2025-12-31) — Change In Income Tax Payable: -10000.00
CRON.TO cash_flow (quarterly, 2025-12-31) — Change In Income Tax Payable: -1000.00
CRON.TO cash_flow (annual, 2025-12-31) — Change In Inventory: -10395000.00
CRON.TO cash_flow (quarterly, 2025-12-31) — Change In Inventory: 2630000.00
CRON.TO cash_flow (annual, 2025-12-31) — Change In Payable: 1098000.00
CRON.TO cash_flow (quarterly, 2025-12-31) — Change In Payable: 2334000.00
CRON.TO cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 3536000.00
CRON.TO cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 8502000.00
CRON.TO cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -1802000.00
CRON.TO cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 546000.00
CRON.TO cash_flow (annual, 2025-12-31) — Change In Receivables: -25753000.00
CRON.TO cash_flow (quarterly, 2025-12-31) — Change In Receivables: -18279000.00
CRON.TO cash_flow (annual, 2025-12-31) — Change In Tax Payable: -10000.00
CRON.TO cash_flow (quarterly, 2025-12-31) — Change In Tax Payable: -1000.00
CRON.TO cash_flow (annual, 2025-12-31) — Change In Working Capital: -34414000.00
CRON.TO cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -6601000.00
CRON.TO cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -16741000.00
CRON.TO cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -6231000.00
CRON.TO cash_flow (annual, 2025-12-31) — Changes In Cash: -70598000.00
CRON.TO cash_flow (quarterly, 2025-12-31) — Changes In Cash: 7194000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Common Stock: 662983000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Common Stock: 662983000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Common Stock Equity: 1093897000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 1093897000.00
CRON.TO cash_flow (annual, 2025-12-31) — Common Stock Payments: -9741000.00
CRON.TO cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -4270000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Construction In Progress: 1062000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 1062000.00
CRON.TO income_statement (annual, 2025-12-31) — Cost Of Revenue: 83828000.00
CRON.TO income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 28342000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 20108000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 20108000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Current Assets: 944086000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Current Assets: 944086000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 337000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 337000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 337000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 337000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Current Liabilities: 48187000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 48187000.00
CRON.TO cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 14231000.00
CRON.TO cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 3657000.00
CRON.TO income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 2119000.00
CRON.TO income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 402000.00
CRON.TO cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 14231000.00
CRON.TO cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 3657000.00
CRON.TO income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 2119000.00
CRON.TO income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 402000.00
CRON.TO income_statement (annual, 2025-12-31) — Diluted Average Shares: 383468522.00
CRON.TO income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 382531225.00
CRON.TO income_statement (annual, 2025-12-31) — Diluted EPS: -0.02
CRON.TO income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.00
CRON.TO income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -9447000.00
CRON.TO income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -1816000.00
CRON.TO cash_flow (annual, 2025-12-31) — Dividends Received Cfi: 0.00
CRON.TO balance_sheet (annual, 2025-12-31) — Dueto Related Parties Non Current: 733000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Dueto Related Parties Non Current: 733000.00
CRON.TO income_statement (annual, 2025-12-31) — EBIT: -19497000.00
CRON.TO income_statement (quarterly, 2025-12-31) — EBIT: -6398000.00
CRON.TO income_statement (annual, 2025-12-31) — EBITDA: -5266000.00
CRON.TO income_statement (quarterly, 2025-12-31) — EBITDA: -2741000.00
CRON.TO income_statement (annual, 2025-12-31) — Earnings From Equity Interest: 0.00
CRON.TO income_statement (quarterly, 2025-12-31) — Earnings From Equity Interest: 0.00
CRON.TO cash_flow (annual, 2025-12-31) — Earnings Losses From Equity Investments: 0.00
CRON.TO cash_flow (quarterly, 2025-12-31) — Earnings Losses From Equity Investments: 0.00
CRON.TO cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 3587000.00
CRON.TO cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 430000.00
CRON.TO cash_flow (annual, 2025-12-31) — End Cash Position: 791794000.00
CRON.TO cash_flow (quarterly, 2025-12-31) — End Cash Position: 791794000.00
CRON.TO income_statement (annual, 2025-12-31) — Excise Taxes: 46776000.00
CRON.TO income_statement (quarterly, 2025-12-31) — Excise Taxes: 13854000.00
CRON.TO cash_flow (annual, 2025-12-31) — Financing Cash Flow: -19905000.00
CRON.TO cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -7423000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Finished Goods: 12012000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Finished Goods: 12012000.00
CRON.TO cash_flow (annual, 2025-12-31) — Free Cash Flow: -190000.00
CRON.TO cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 9561000.00
CRON.TO cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: 446000.00
CRON.TO cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: 3928000.00
CRON.TO income_statement (annual, 2025-12-31) — Gain On Sale Of Ppe: -5532000.00
CRON.TO income_statement (quarterly, 2025-12-31) — Gain On Sale Of Ppe: 0.00
CRON.TO income_statement (annual, 2025-12-31) — Gain On Sale Of Security: -29040000.00
CRON.TO income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: -14345000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -16842000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -16842000.00
CRON.TO income_statement (annual, 2025-12-31) — General And Administrative Expense: 49049000.00
CRON.TO income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 14148000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Goodwill: 66478000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Goodwill: 66478000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 75368000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 75368000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 34108000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 34108000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Gross PPE: 296748000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Gross PPE: 296748000.00
CRON.TO income_statement (annual, 2025-12-31) — Gross Profit: 62759000.00
CRON.TO income_statement (quarterly, 2025-12-31) — Gross Profit: 16189000.00